Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Short-chain fructo-oligosaccharides (scFOS) are a class of non-digestible carbohydrates composed of linear fructose chains, typically with a degree of polymerization between 2 and 5, often ending in a glucose unit. They are primarily recognized as prebiotics that selectively stimulate the growth and activity of beneficial gut bacteria, such as Bifidobacterium and Lactobacillus species. Upon reaching the colon, scFOS undergo fermentation by the resident microbiota, leading to the production of short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. These SCFAs play a crucial role in maintaining intestinal health by lowering colonic pH, providing energy to colonocytes, and enhancing the intestinal barrier. Additionally, scFOS have been shown to improve mineral absorption, particularly magnesium and calcium, and modulate the immune system through interactions with gut-associated lymphoid tissue. While not a traditional therapeutic target, scFOS are utilized in clinical settings and functional foods to manage metabolic conditions like obesity and prediabetes, as well as to alleviate constipation. They are generally regarded as safe, although high doses can cause gastrointestinal side effects such as flatulence and bloating.
Selective fermentation by colonic bacteria into short-chain fatty acids (SCFAs), which lowers intestinal pH, inhibits pathogen growth, and supports colonocyte health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Short-chain fructo-oligosaccharides (scFOS).